Erin Wright
Stock Analyst at Morgan Stanley
(4.55)
# 218
Out of 5,090 analysts
242
Total ratings
64.94%
Success rate
15.1%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $118.65 | +47.49% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $808.62 | +13.28% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $73.62 | -21.22% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $714.10 | +12.73% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $157.21 | -2.04% | 25 | Oct 30, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $29.89 | +17.10% | 1 | Oct 17, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $163 → $204 | $151.86 | +34.33% | 3 | Oct 14, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $316 → $359 | $330.75 | +8.54% | 4 | Oct 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $89 | $75.63 | +17.68% | 6 | Oct 14, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $25 → $32 | $35.79 | -10.59% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $139.36 | +0.46% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $20.23 | -15.97% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $290 → $277 | $257.85 | +7.43% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $339.66 | -2.84% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $198.83 | -4.44% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $39.16 | -33.61% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $265.44 | +46.93% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $1.65 | +93.94% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $13 | $21.90 | -40.64% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.25 | +104.44% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $182.51 | -5.76% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $330.91 | +77.39% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $258.39 | +16.10% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $10.93 | +284.26% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $226.25 | +27.29% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $184.31 | +90.98% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.70 | +1,089.19% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $548.12 | -66.98% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $63.30 | -73.14% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $33.47 | +261.52% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $572.77 | +1.26% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $9.22 | +279.61% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $185.80 | +10.33% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $27.79 | -60.42% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $225.85 | -30.48% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $2.59 | +556.37% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $452.20 | -31.89% | 1 | Oct 25, 2017 |
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $118.65
Upside: +47.49%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $808.62
Upside: +13.28%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $73.62
Upside: -21.22%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $714.10
Upside: +12.73%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $157.21
Upside: -2.04%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $29.89
Upside: +17.10%
Molina Healthcare
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $151.86
Upside: +34.33%
Elevance Health
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $316 → $359
Current: $330.75
Upside: +8.54%
CVS Health
Oct 14, 2025
Maintains: Overweight
Price Target: $82 → $89
Current: $75.63
Upside: +17.68%
BrightSpring Health Services
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $35.79
Upside: -10.59%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $139.36
Upside: +0.46%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $20.23
Upside: -15.97%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $290 → $277
Current: $257.85
Upside: +7.43%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $339.66
Upside: -2.84%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $198.83
Upside: -4.44%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $39.16
Upside: -33.61%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $265.44
Upside: +46.93%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $1.65
Upside: +93.94%
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $21.90
Upside: -40.64%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.25
Upside: +104.44%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $182.51
Upside: -5.76%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $330.91
Upside: +77.39%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $258.39
Upside: +16.10%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $10.93
Upside: +284.26%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $226.25
Upside: +27.29%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $184.31
Upside: +90.98%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.70
Upside: +1,089.19%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $548.12
Upside: -66.98%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $63.30
Upside: -73.14%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $33.47
Upside: +261.52%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $572.77
Upside: +1.26%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $9.22
Upside: +279.61%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $185.80
Upside: +10.33%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $27.79
Upside: -60.42%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $225.85
Upside: -30.48%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $2.59
Upside: +556.37%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $452.20
Upside: -31.89%